Replies to post #31613 on Lexaria Bioscience Corp (LEXX)

[Shawking]

A high-throughput screening campaign of a library of approved drugs and clinical candidates revealed six small molecules, ebselen, disulfiram, carmofur, tideglusib, shikonin and PX-12, as inhibitors of SARS-CoV-2 Mpro